The largest database of trusted experimental protocols

Human osteogenic differentiation media

Manufactured by Cell Applications
Sourced in United States

Human osteogenic differentiation media is a cell culture medium designed to support the differentiation of human cells into osteogenic (bone-forming) lineages. It provides the necessary growth factors and nutrients to promote the development of mature osteoblasts from progenitor cells.

Automatically generated - may contain errors

2 protocols using human osteogenic differentiation media

1

Fabrication of Osteogenic hMSC Spheroids

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human bone marrow-derived mesenchymal stem cells (hMSCs, RoosterBio Inc., MD, USA) were used to fabricate spheroids. Cells at passages from 4 through 7 were used. hMSCs were cultured in mesenchymal stem cell expansion media (R&D Systems, MN, USA) at 37 °C in 5% CO2 in a humidified sterile incubator. To prepare hMSC only spheroids, the expanded hMSCs were trypsinized, centrifuged, and transferred to each well of a U-bottom 96-well plate (Greiner Bio One, Austria) with 15,000–20,000 cells per well. Spheroids were obtained with a size of 400–800 μm as we reported before (11 ). Bioprinted spheroids were then cultured in human osteogenic differentiation media (Cell Applications Inc., USA) for 28 days post-bioprinting to enable their differentiation into an osteogenic lineage. The differentiation media was changed every 2–3 days.
+ Open protocol
+ Expand
2

Osteogenic Differentiation of Rat and Human MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
For in-vitro study, human mesenchymal stem cells (hMSCs, RoosterBio Inc., MD, USA) were cultured using MSC expansion media (R&D Systems, MN, USA) (growth media; GM) supplemented with Penicillin (100 IU/ml) - Streptomycin (100 μg/ml) (cat. no. 30–002-CI, Corning Life Sciences, Lowell, MA) until usage. As an osteogenic media (OM), human osteogenic differentiation media (Cell Applications, USA) added with Penicillin-Streptomycin was used.
For in-vivo study, as implantation of hMSCs was not possible into immunocompetent rats, allogenic rBMSCs were extracted from inbred 4-week-old male Fischer white rats (F344/DuCrl, Charles River Laboratories, Wilmington, MA) [25 ]. All animals were cared in the animal facility (Millennium Science Complex, PSU) and euthanasia procedures were according to American Association for Laboratory Animal Science (AALAS) and The Institutional Animal Care and Use Committee (IACUC protocol #46591). Isolated rBMSCs were plated on 6-well cell culture plates in Minimal Eagle’s Medium, Alpha modification (αMEM; cat. no. 10–022-CV, Corning Cellgro®, Manassas, VA) supplemented with 10% fetal bovine serum (FBS) (cat. no. 35–010-cv, Thermo Fisher Scientific, Waltham, WA), PS and 2.5 μg/ml Fungizone (cat. no. 15–290-026, Thermo Fisher Scientific) and incubated at 37 °C in a humidified 5% CO2 incubator.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!